Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27


Chronic infection with the protozoan Toxoplasma gondii prevents the development of experimental atopic dermatitis in mice.

Perrone Sibilia MD, Aldirico MLÄ, Soto AS, Picchio MS, Sánchez VR, Arcón N, Moretta R, Martín V, Vanzulli S, Fenoy IM, Goldman A.

J Dermatol Sci. 2019 Nov 2. pii: S0923-1811(19)30339-1. doi: 10.1016/j.jdermsci.2019.10.007. [Epub ahead of print]


Phenotype of haptoglobin and presence of subclinical vascular disease: Population study.

Mostaza JM, de Dios O, Lahoz C, Arribas M, Pérez Arroyo A, Salinero-Fort MA, Laguna F, Estirado E, García-Iglesias F, González Alegre T, Sabín C, López S, Sánchez V, Cornejo V, Garcés C; en representación de los investigadores del estudio ESPREDIA.

Clin Investig Arterioscler. 2019 Jun 17. pii: S0214-9168(19)30050-6. doi: 10.1016/j.arteri.2019.03.007. [Epub ahead of print] English, Spanish.


The transcription factor CBFB suppresses breast cancer through orchestrating translation and transcription.

Malik N, Yan H, Moshkovich N, Palangat M, Yang H, Sanchez V, Cai Z, Peat TJ, Jiang S, Liu C, Lee M, Mock BA, Yuspa SH, Larson D, Wakefield LM, Huang J.

Nat Commun. 2019 May 6;10(1):2071. doi: 10.1038/s41467-019-10102-6.


Topical Application of a Dual ABC Transporter Substrate and NF-κB Inhibitor Blocks Multiple Sources of Cutaneous Inflammation in Mouse Skin.

Li L, Cataisson C, Flowers B, Fraser E, Sanchez V, Day CP, Yuspa SH.

J Invest Dermatol. 2019 Jul;139(7):1506-1515.e7. doi: 10.1016/j.jid.2018.12.026. Epub 2019 Jan 23.


Genotyping of Toxoplasma gondii: The advantages of variable number tandem repeats within coding regions.

Moretta R, Sanchez VR, Fenoy IM, Goldman A, Ruybal P, Martin V.

Infect Genet Evol. 2018 Nov;65:226-230. doi: 10.1016/j.meegid.2018.07.026. Epub 2018 Jul 23.


R46L polymorphism in the PCSK9 gene: Relationship to lipid levels, subclinical vascular disease, and erectile dysfunction.

Mostaza JM, Lahoz C, Salinero-Fort MA, de Dios O, Castillo E, González-Alegre T, García-Iglesias F, Estirado E, Laguna F, Sabín C, López S, Cornejo V, de Burgos C, Sanchez V, Garcés C; investigators of the SPREDIA-2 Group.

J Clin Lipidol. 2018 Jul - Aug;12(4):1039-1046.e3. doi: 10.1016/j.jacl.2018.04.004. Epub 2018 Apr 21.


Relationship of the Adherence to a Mediterranean Diet and Its Main Components with CRP Levels in the Spanish Population.

Lahoz C, Castillo E, Mostaza JM, de Dios O, Salinero-Fort MA, González-Alegre T, García-Iglesias F, Estirado E, Laguna F, Sanchez V, Sabín C, López S, Cornejo V, de Burgos C, Garcés C; Investigators of the SPREDIA-2 Group.

Nutrients. 2018 Mar 20;10(3). pii: E379. doi: 10.3390/nu10030379.


Vaccine potential of antigen cocktails composed of recombinant Toxoplasma gondii TgPI-1, ROP2 and GRA4 proteins against chronic toxoplasmosis in C3H mice.

Picchio MS, Sánchez VR, Arcon N, Soto AS, Perrone Sibilia M, Aldirico MLA, Urrutia M, Moretta R, Fenoy IM, Goldman A, Martin V.

Exp Parasitol. 2018 Feb;185:62-70. doi: 10.1016/j.exppara.2018.01.006. Epub 2018 Jan 6.


Toxoplasma gondii serine-protease inhibitor-1: A new adjuvant candidate for asthma therapy.

Soto AS, Fenoy IM, Sanchez VR, March F, Perrone Sibilia MD, Aldirico MLA, Picchio MS, Arcon N, Acosta PL, Polack FP, Martin V, Goldman A.

PLoS One. 2017 Oct 26;12(10):e0187002. doi: 10.1371/journal.pone.0187002. eCollection 2017.


Elevating CLIC4 in Multiple Cell Types Reveals a TGF- Dependent Induction of a Dominant Negative Smad7 Splice Variant.

Shukla A, Yang Y, Madanikia S, Ho Y, Li M, Sanchez V, Cataisson C, Huang J, Yuspa SH.

PLoS One. 2016 Aug 18;11(8):e0161410. doi: 10.1371/journal.pone.0161410. eCollection 2016. Erratum in: PLoS One. 2016 Dec 12;11(12 ):e0168629.


Homologous prime-boost strategy with TgPI-1 improves the immune response and protects highly susceptible mice against chronic Toxoplasma gondii infection.

Sánchez VR, Fenoy IM, Picchio MS, Soto AS, Arcon N, Goldman A, Martin V.

Acta Trop. 2015 Oct;150:159-65. doi: 10.1016/j.actatropica.2015.07.013. Epub 2015 Jul 19.


A Phase I clinical trial with subcutaneous immunotherapy vaccine of Timothy grass pollen extract according to EMA guidelines.

Sola J, Sánchez V, Landeta A, Madariaga B, Martínez A, Álvarez-Cuesta E.

Immunotherapy. 2015;7(4):343-52. doi: 10.2217/imt.15.8.


Toxoplasma gondii infection modulate systemic allergic immune response in BALB/c mice.

Fenoy IM, Sánchez VR, Soto AS, Picchio MS, Martin V, Goldman A.

Exp Parasitol. 2015 Jul;154:47-50. doi: 10.1016/j.exppara.2015.04.001. Epub 2015 Apr 14.


Regulatory cells induced by acute toxoplasmosis prevent the development of allergic lung inflammation.

Fenoy IM, Sanchez VR, Soto AS, Picchio MS, Maglioco A, Corigliano MG, Dran GI, Martin V, Goldman A.

Immunobiology. 2015 May;220(5):641-8. doi: 10.1016/j.imbio.2014.11.016. Epub 2014 Dec 13.


A chloroplast-derived Toxoplasma gondii GRA4 antigen used as an oral vaccine protects against toxoplasmosis in mice.

Del L Yácono M, Farran I, Becher ML, Sander V, Sánchez VR, Martín V, Veramendi J, Clemente M.

Plant Biotechnol J. 2012 Dec;10(9):1136-44. doi: 10.1111/pbi.12001. Epub 2012 Oct 1.


Toxoplasma gondii infection induces suppression in a mouse model of allergic airway inflammation.

Fenoy IM, Chiurazzi R, Sánchez VR, Argenziano MA, Soto A, Picchio MS, Martin V, Goldman A.

PLoS One. 2012;7(8):e43420. doi: 10.1371/journal.pone.0043420. Epub 2012 Aug 28.


CCS52 and DEL1 genes are key components of the endocycle in nematode-induced feeding sites.

de Almeida Engler J, Kyndt T, Vieira P, Van Cappelle E, Boudolf V, Sanchez V, Escobar C, De Veylder L, Engler G, Abad P, Gheysen G.

Plant J. 2012 Oct;72(2):185-98. doi: 10.1111/j.1365-313X.2012.05054.x. Epub 2012 Aug 23.


Biological interactions of graphene-family nanomaterials: an interdisciplinary review.

Sanchez VC, Jachak A, Hurt RH, Kane AB.

Chem Res Toxicol. 2012 Jan 13;25(1):15-34. doi: 10.1021/tx200339h. Epub 2011 Oct 21. Review.


A 3-dimensional in vitro model of epithelioid granulomas induced by high aspect ratio nanomaterials.

Sanchez VC, Weston P, Yan A, Hurt RH, Kane AB.

Part Fibre Toxicol. 2011 May 18;8:17. doi: 10.1186/1743-8977-8-17.


Combination of CpG-oligodeoxynucleotides with recombinant ROP2 or GRA4 proteins induces protective immunity against Toxoplasma gondii infection.

Sánchez VR, Pitkowski MN, Fernández Cuppari AV, Rodríguez FM, Fenoy IM, Frank FM, Goldman A, Corral RS, Martin V.

Exp Parasitol. 2011 Aug;128(4):448-53. doi: 10.1016/j.exppara.2011.04.004. Epub 2011 May 1.


Supplemental Content

Loading ...
Support Center